Literature DB >> 8964083

Cocaine down-regulates IL-2-induced peripheral blood lymphocyte IL-8 and IFN-gamma production.

J T Mao1, M Huang, J Wang, S Sharma, D P Tashkin, S M Dubinett.   

Abstract

Cocaine has multiple immunomodulatory effects, including the ability to influence cytokine release in immunoeffector cells. Little is known, however, regarding the effects of cocaine on cytokine production by human peripheral blood lymphocytes (PBL). The effect of cocaine on PBL cytokine profiles and the molecular mechanisms responsible for the modulation of cytokine mRNA expression were investigated. To evaluate the effects of cocaine on cytokine production, conditioned supernatant from IL-2-stimulated PBL was evaluated by cytokine-specific ELISA (IL-4, IL-5, IL-8, IL-10, IFN-gamma, and TGF-beta) following in vitro cocaine exposure. Cocaine abrogated the IL-2-induced production of IFN-gamma and IL-8 in a dose-responsive manner. Cocaine also decreased PBL IFN-gamma and IL-8 mRNA expression as determined by Northern blot and slot blot analysis. Cocaine did not affect the stability of the IFN-gamma and IL-8 mRNA. Nuclear run-on assays revealed that cocaine down-regulated the rate of IFN-gamma and IL-8 transcription. These findings suggest that the immunomodulatory effects of cocaine may be mediated, in part, by modification of lymphocyte cytokine production.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8964083     DOI: 10.1006/cimm.1996.0235

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  15 in total

1.  Effects of cocaine administration to influenza virus-immunized mice on cytokine profiles of individual splenic CD4+ and CD8+ T cells.

Authors:  P Di Francesco; R Falchetti; R Gaziano; G Lanzilli; I A Casalinuovo; G Ravagnan; E Garaci
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

Review 2.  Microbial infections, immunomodulation, and drugs of abuse.

Authors:  Herman Friedman; Catherine Newton; Thomas W Klein
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

Review 3.  Cocaine and HIV-1 interplay in CNS: cellular and molecular mechanisms.

Authors:  Shilpa Buch; Honghong Yao; Minglei Guo; Tomohisa Mori; Blaise Mathias-Costa; Vijeta Singh; Pankaj Seth; John Wang; Tsung-Ping Su
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

4.  Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.

Authors:  Randi Melissa Schuster; Raul Gonzalez
Journal:  Neurobehav HIV Med       Date:  2012-02-16

Review 5.  Rodent models of HAND and drug abuse: exogenous administration of viral protein(s) and cocaine.

Authors:  Honghong Yao; Shilpa Buch
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-24       Impact factor: 4.147

Review 6.  Cocaine and HIV-1 interplay: molecular mechanisms of action and addiction.

Authors:  Shilpa Buch; Honghong Yao; Minglei Guo; Tomohisa Mori; Tsung-Ping Su; John Wang
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-16       Impact factor: 4.147

7.  Cocaine Use May be Associated with Increased Depression in Persons Infected with HIV.

Authors:  Edward R Hammond; Shenghan Lai; Carolyn M Wright; Glenn J Treisman
Journal:  AIDS Behav       Date:  2016-02

Review 8.  The effects of cocaine on HIV transcription.

Authors:  Mudit Tyagi; Jaime Weber; Michael Bukrinsky; Gary L Simon
Journal:  J Neurovirol       Date:  2015-11-16       Impact factor: 2.643

9.  Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse.

Authors:  Linda Chang; Gene-Jack Wang; Nora D Volkow; Thomas Ernst; Frank Telang; Jean Logan; Joanna S Fowler
Journal:  Neuroimage       Date:  2008-05-20       Impact factor: 6.556

10.  Cocaine-mediated enhancement of virus replication in macrophages: implications for human immunodeficiency virus-associated dementia.

Authors:  Navneet K Dhillon; Rachel Williams; Fuwang Peng; Yi-Jou Tsai; Sukhbir Dhillon; Brandon Nicolay; Milind Gadgil; Anil Kumar; Shilpa J Buch
Journal:  J Neurovirol       Date:  2007-12       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.